乳腺1号方治疗肝郁气滞型乳腺增生病疗效观察

Observation on the Effects of Mammary Gland 1 Prescription on Mammary Gland Hyperplasia of Liver Qi Stagnation Type

目的 :观察乳腺1号方治疗肝郁气滞型乳腺增生病的临床效果。方法 :将72例肝郁气滞型乳腺增生病患者采用随机数字表法分为治疗组、对照组各36例。治疗组给予自拟乳腺1号方内服外敷,对照组给予乳块消片口服。两组均30 d为1疗程,连服3疗程。观察两组临床疗效和治疗前后血清性激素水平。结果:治疗后治疗组总有效率显著高于对照组,两组之间差异有统计学意义(P<0.05)。两组治疗后血清雌二醇(E2)、垂体催乳素(PRL)水平下降,治疗组明显优于对照组(P<0.05)。结论 :自拟乳腺1号方内服外敷治疗肝郁气滞型乳腺增生病的临床疗效显著,且不易复发。

Objective：To observe the clinical effects of mammary gland 1 prescription on mammary gland hyperplasia of liver Qi stagnation type. Methods：Total 72 patients with mammary gland hyperplasia of liver Qi stagnation type were randomly divided into the treatment group and control group with 36 cases respectively. Mammary gland 1 prescription was given to the treatment group by internal and external treatment while Rukuaixiao tablets were given to the control group,both for 3 courses,30 days for a course to observe the clinical effect and the serum sex hormone changes before and after the treatment. Results：The total effective rate of the treatment group was significantly higher than that of the control group with statistical significance（P〈0.05）. The serum levels of E2 and PRL reduced in the two groups and the treatment group had better effect than the control group（P〈0.05）. Conclusion：The clinical effects of mammary gland1 prescription on mammary gland hyperplasia were remarkable by the internal and external treatment and not easy to relapse.